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Background.The aim of this study was to determine the incidence of tuberculosis and its predictors among HIV positive children.
Methods. A six-year retrospective follow-up study was conducted among HIV infected children aged less than 15 years. Life table
was used to estimate the cumulative probability of tuberculosis free survival. Cox proportional hazards model was used to identify
predictors of tuberculosis. Results. A total of 271 HIV positive children were followed for six years and produced 1100.50 person-
years of observation. During the follow-up period 52 new TB cases occurred. The overall incidence density of TB was 4.9 per 100
PY. Inappropriate vaccination [AHR: 8.03 (95% CI; 4.61–13.97)], ambulatory functional status [AHR: 1.99 (95% CI; 1.04–3.81)],
and having baseline anemia [AHR: 2.23 (95% CI; 1.19–4.15)] were important predictors of time to TB occurrence. Conclusion. TB
incidence rate was high. Early diagnosis and treatment of anemia and strengthening immunization program would reduce the risk
of TB occurrence.
1. Background
Tuberculosis (TB) is a leading cause of morbidity and mor-
tality among HIV infected children. Worldwide, there are
approximately nine million new TB cases each year and 13%
coinfected with HIV [1, 2]. In 2011, there were estimated 9.2
million new cases of TB, with ten percent of those occurring
in children, almost one million new pediatric cases each year
[3–5]. TB is among the top ten causes of death among children
[6]. One of three HIV coinfected patients dies because of TB
and the disease will become worse if it was left untreated
[7]. TB accounts for 26% of AIDS-related deaths, of which
99% occur in developing countries [8]. In resource limited
countries, TB is the most common opportunistic infection in
children with HIV [9–12].
Several studies in Africa have shown that the incidence
of TB among HIV positive children ranges from 1 to 9.9 per
100 PY [13–17].
In previous studies, severe wasting, severe immune sup-
pression, anemia, andWHO stage IV were all independently
associated with a higher risk of TB. In addition, the use of
antiretroviral drugs for more than 180 days reduced the risk
of TB [13]. Early initiation of ART (particularly before 12
weeks of age) in HIV infected infants regardless of clinical
or CD4 count criteria significantly reduces mortality and TB
incidence. Isoniazid preventive therapy (IPT) for TB-exposed
infants is an important additional TBprevention strategy [18].
In Ethiopia, childhood TB is still a major cause of hospital
admission and death [13]. In 2011, the number of new HIV
infections among childrenwas 13 000, 19% of eligible children
younger than 15 years old receiving antiretroviral therapy [2].
But studies on various aspects of childhood tuberculosis are
rare. Hence, studying the incidence of tuberculosis and its
predictors among HIV positive children will have a great
importance for the health care system in making appropriate
adjustments and allocating resources as a solution.
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2. Methods
2.1. StudyDesign and Setting. A retrospective follow-up study
was conducted in August 2013 at the University of Gondar
Referral Hospital pediatrics HIV care clinic, which is located
in Northwest Ethiopia. The hospital is the only tertiary
hospital located in the historical city of Gondar, serving for
more than fivemillion people. During the study period, there
were a total of 907 children ever enrolled into pediatrics
chronic HIV care and follow-up clinic, 597 ever started ART,
and the rest were pre-ART.
2.2. Definition of Tuberculosis. In the study setting, TB is
diagnosed using chest radiology, fine needle aspiration, and
cytology with very high clinical suspicion. When a child is
diagnosed with active TB, the treatment is given according to
the national TB treatment guideline. The event of this study
was new occurrence of TB, which is defined as occurrence
of TB in HIV infected children during the follow-up period
at any time after enrollment to pediatrics HIV care clinic.
Children, who were lost, died, or transferred out or did not
develop the events until the last visit were considered as
censored. In this study, severe immunodeficiencywas defined
as CD4 count below the threshold according to the child’s
age; for infants CD4 <1500/mm3 (<25%), 12–35 months
<750mm3 (<20%), 36–59 months <350mm3 (<15%), and
five years and above <200/mm3 (<15%). Those HIV positive
children above the threshold were classified as not severe
immunodeficiency.
2.3. Inclusion and Exclusion Criteria. All HIV positive chil-
dren below 15 years of age and newly enrolled into pediatric
chronic HIV care clinic at the University of Gondar Referral
Hospital from September 2006 to August 2010 were included
in this study (Figure 1). Those HIV positive children who
started anti-TB treatment at the beginning of the follow-
up and those with incomplete baseline information such as
CD4 count and hemoglobin (Hgb) level were excluded from
the study. Finally, two hundred seventy-one children who
fulfilled the inclusion criteria were included in this study.
2.4. Data Collection. All available information on patient
registration book was checked and an appropriate data
extraction tool was prepared.Then, data were extracted from
patients’ registration book by two health professionals who
had ART training and have been working in HIV care clinic.
2.5. Data Analysis. Data were entered and cleaned using EPI
INFO version 3.5.3 and exported to SPSS version 20 for
analysis. Nutritional status was assessed using Anthro plus
software. Summary statistics and incidence density rate were
calculated. Life table was used to estimate the cumulative
probability of TB free survival and Kaplan-meier to estimate
the median TB free survival time. Bivariate and multivari-
ate Cox proportional hazards model was used to identify
predictors of time to TB occurrence. Adjusted Hazard Ratio
(AHR) with 95% confidence intervals (CI) was computed







0.00 20.00 40.00 60.00 80.00 100.00














Figure 1: TB free survival proportion of HIV positive children at
pediatrics HIV care clinic of University of Gondar Referral Hospital,
from September 2006 to August 2013.
The necessary assumptions for Cox proportion hazardmodel
were checked using the Schoen field residual test.
3. Ethical Considerations
Ethical clearance was obtained from the institutional review
board of the University of Gondar. Formal letter of per-
mission was obtained from the chief executive officer of
the hospital. The Pediatrics ART head gave the consent for
extracting data from records. Patients’ names and identifica-
tion numbers were not extracted to ensure confidentiality of
patient information.
4. Results
4.1. Sociodemographic Characteristics of the Study Partici-
pants. Two hundred seventy-oneHIV infected childrenwere
included in the analysis. The mean age was 6.42 (±3.53 SD)
years and 41% of themwere under 5 years. Slightly more than
half (51.7%) of them were females and about 85% of them
were from urban areas. One in every eight (12.5%) children
was double orphan, who lost both of their partners, and
one-third of them were living with more than 5 family sizes
(Table 1).
4.2. Baseline Clinical Characteristics of Study Participants.
Slightly more than half (53.9%) of HIV positive children had
a baseline CD4 count of 350 and above. About 16% of them
were anemic during enrolment. The baseline median CD4
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Table 1: Sociodemographic characteristics of HIV positive children
at pediatrics HIV care clinic of the University of Gondar Referral
Hospital, Northwest Ethiopia, from September 2006 to August 2010.
Characteristics Categories Frequency Percent






Residence Urban 231 85.2
Rural 40 14.8
Parental status
Both parents alive 138 50.9
Paternal orphan 56 20.7
Maternal orphan 34 12.5
Double orphan 34 12.5








Grand parents 26 9.6
Guardians 12 4.4
Orphanage centers 6 2.2
and Hgb level were 388 (IQR; 193–716) and 12 (IQR; 11.3–
13), respectively. During their follow-up, Co-Trimoxazole
PreventiveTherapy (CPT) was provided nearly for all (97.8%)
of patients and about 52% of them received Isoniazid (INH)
prophylaxis. Nearly two-third (62%) of them were stunted.
During enrolment, about 55%, 37.3%, and 28.1%HIV positive
children had functional status of ambulatory, working, and
being bedridden, respectively. Nearly one-fifth (16.6%) had
past history of TB treatment, and about 11%of themdefaulted.
4.3. Tuberculosis Incidence Rate. Two hundred seventy-one
study subjects were followed up for different periods ranging
fromonemonth to six yearswhich resulted in 1100.49 person-
years of observation. The mean follow-up time was 48.73
months (SD ± 17.87). Within the follow-up period, one-fifth
(19.9%) of new tuberculosis cases were observed and 11%were
transferred out.The overall TB incidence density rate was 4.9
per 100 PY.
Nearly three-quarters (70.3%) were pulmonary tubercu-
losis. Similar proportions (70.3%) of Tb cases were on ART.
The cumulative probability of TB free survival at the end of 6
monthswas 0.96; at the end of a year, 0.94; and that of survival
at the end of three years was 0.84 and at the end of six years
was 0.76. The median survival time from enrolment to TB
occurrence was 72 months.
4.4. Predictors of Time to TB Occurrence. In bivariate Cox-
regression analysis, paternal orphans, baseline WHO clinical
stage IV, and having baseline anemia and being ambulatory
and inappropriately vaccinated were significantly associated
with incidence of TB amongHIV positive children. However,
in multivariate Cox-regression analysis, being inappropri-
ately vaccinated and having baseline anemia and ambulatory
functional status remained significant predictors of TBoccur-
rence.
Those HIV infected children who had inappropriate
vaccination were about 8 times (AHR 8.03 (95% CI; 4.61–
13.97)) higher risk of developing TB at any time as compared
to the counterpart. Those HIV infected children who had
baseline anima are 2.2 (AHR 2.23 (95% CI; 1.19–4.15)) times
higher risk of developing TB at any time as compared to
those HIV infected children who had no baseline anemia.
HIV infected children who had ambulatory function status at
enrollment were at 1.9 (AHR 1.99 (95% CI; 1.04–3.81)) times
higher risk of developing TB compared to those who were
working (Table 2).
5. Discussion
This study revealed that the overall incidence density rate
of TB among HIV positive children at University of Gondar
Referral Hospital was 4.9 PY. It was similar with the finding
from a cohort study in Tanzania (5.2 cases per 100 PY)
[13]. But, this finding is higher than that of studies done
in Kenya and South Africa which were 1.4 and 1.0 per
100 PY, respectively [14, 15]. The discrepancies in incidence
rate may be due to the difference in follow-up period of
the studies and the difference in the overall burden of TB
in the general population. But the rate was lower than the
finding from a cohort study in FelegeHiwot Referral Hospital
(Northern Ethiopia) which was 9.9 per 100 PY (7 cases out of
56 children followed up for 70.50 PY) [19]. This may be due
to the difference in the study population (mixed adult and
pediatric).
This study found that HIV positive children with baseline
anemia had 2.23 times higher risk of developing TB as
compared to nonanemic children which is similar to the
studies done in Tanzania and Northern Ethiopia [13, 19].
This could be due to the fact that children were affected by
infections when their Hgb level is lower than 12 g/dL. As a
result, they become at higher risk for TB.
This study also found that patients with baseline ambula-
tory functional status had 2 times higher risk of developing
TB as compared to working functional status. This finding
is similar to the study done in Northern Ethiopia [20]. This
could be due to the fact that patients lose their functional
status as a result of many infectious diseases when they are
anemic.
This study also revealed that patients who were not
appropriately vaccinated had 8.03 times higher risk of devel-
oping TB as compared to vaccinated children. Similar finding
in Tanzania showed that BCG scar was associated with a
reduced risk of TB, as research showed BCG vaccination
considerably reduced the risk of TB, both among individuals
with and without HIV infection [21].
Unlike the previous studies, the current study found
that baseline clinical factors like immune suppression, WHO
stage, ART status, and nutritional status were not associated
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Table 2: Cox-regression analysis of predictors of incidence of TB among HIV infected children at University of Gondar Referral Hospital
(𝑛 = 271).
Variables TB incidence CHR (95% CI) AHR (95% CI)Event Censored
Sex
Male 28 103 1
Female 26 114 0.84 (0.49–1.43)
Age
<5 18 93 0.87 (0.41–1.84)
5–9 25 77 1.33 (0.65–2.69)
10–14 11 47 1
Residence
Urban 44 187 1
Rural 10 30 1.58 (0.79–3.15)
Family size
≤2 6 23 1
3-4 31 119 0.94 (0.39–2.26)
≥5 17 75 0.82 (0.32–2.07)
Parental status
Both parents a live 22 116 1
Paternal orphan 17 39 2.05 (1.09–3.87)
Maternal orphan 7 27 1.26 (0.54–2.95)
Double orphan 5 29 0.90 (0.34–2.38)
Not recorded 3 6 2.27 (0.68–7.58)
WHO clinical stage
I 10 73 1
II 13 59 1.49 (0.65–3.41)
III 23 71 2.06 (0.98–4.33)
IV 8 14 3.66 (1.44–9.29)
Anemia
Anemia 15 27 2.47 (1.36–4.49) 2.23 (1.19–4.15)
No Anemia 39 190 1
Immunodeficiency
Severe 20 77 1.08 (0.62–1.87)
Not severe 34 140 1
ART at initial
Yes 22 90 1.10 (0.64–1.91)
No 32 127 1
IPT
Yes 28 114 1.09 (0.64–1.85)
No 26 118 1
CPT
Yes 53 212 0.82 (0.11–5.96)
No 1 5 1
Past TB treatment history
Yes 11 34 0.82 (0.11–5.96)
No 43 183 1
Functional status
Working 13 88 1
Ambulatory 37 111 2.21 (1.17–4.19) 1.99 (1.04–3.81)
Bedridden 4 18 1.50 (0.49–4.61) 0.92 (0.29–2.92)
Vaccination status
Vaccinated 22 174 1
Not appropriately vaccinated 31 22 7.86 (4.54–13.62) 8.03 (4.61–13.97)
Not recorded 1 21 0.36 (0.05–2.64) 0.42 (0.06–3.15)
Nutritional status
Normal 19 84 1
Stunted 35 133 1.07 (0.61–1.87)
COR = Crude hazard ratio, AOR = Adjusted Hazard Ratio, and CI = confidence interval.
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with occurrence of TB. For instance, a study in Tanzania
reported severe wasting (RR 1.8, 95% CI 1.3–2.5), severe
immune suppression (RR 2.6, 95% CI 1.8–3.8), and WHO
stage IV (RR 4.5, 95% CI 2.4–8.5) were all independently
associated with a higher risk of TB [21]. In addition, the
use of antiretroviral drugs for more than 180 days reduced
the risk of TB by 70% (RR 0.3, 95% CI 0.2–0.4) [21]. The
discrepancy might be due to methodology, study setting, and
time variations.
The retrospective nature of the study was one of the
limitations of this study. As a result, some of the important
predictors which had a significant association with the TB
occurrence in other studies like income were not included in
this study.
6. Conclusion
Incidence of TB was high among HIV infected children,
especially after the first six months of enrolment in HIV care.
The baseline anemia, ambulatory functional status, and those
who were not appropriately vaccinated were significantly
associated with the incidence of tuberculosis. Therefore,
early diagnosis and treatment of anemia and strengthening
immunization program are recommended to reduce the risk
of TB occurrence among HIV infected children.
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